TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”), supporting ...

USA: The recent RELIEVE-HF trial has revealed the efficacy of transcatheter interatrial shunt implantation as a treatment for ...

Bisoprolol is clinically feasible option in reducing resting heart rate (RHR) and improving left ventricular ejection ...

Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, ...

The following is a summary of “Cardiopulmonary Ultrasound to Predict Care Escalation in Early Sepsis: A Pilot Study,” ...

Tectonic Therapeutic (TECX) announced positive interim data from the Phase 1b acute hemodynamic clinical trial of its lead product candidate, ...

Aims Exercise testing remains underused in patients with aortic stenosis (AS), partly due to concerns about an ...

Tectonic Therapeutic shares doubled, to $56.80, after the company said it saw positive interim data from a Phase 1b acute hemodynamic clinical trial of its lead product candidate, TX45, a long-acting, ...

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

Vermont Business Magazine Central Vermont Home Health & Hospice (CVHHH) received a $10,000 grant from the Vermont Mutual Charitable Giving Fund. The grant will help fund CVHHH’s Adult Home Care ...

The trial's safety results were reassuring, with no serious adverse events or significant changes in vital signs, physical exams, or safety laboratory values post-administration of TX45. Transient ...